Related Experiment Video
Updated: Apr 28, 2026

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion
Published on: August 29, 2018
Transcriptome Analysis Identifies Proteostasis and Cell Survival Pathway Disruption in Peripartum Cardiomyopathy,
Pooja Choubey1, Vanessa Montoya-Uribe2, Michelle L Matter1
1The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Peripartum cardiomyopathy (PPCM) results from pregnancy stress overwhelming heart adaptation. This study reveals PPCM involves failed protein quality control and impaired translation, offering new therapeutic targets for heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Genomics
Background:
- Peripartum cardiomyopathy (PPCM) is a rare but serious form of heart failure during late pregnancy or postpartum.
- The precise molecular mechanisms linking pregnancy stress to cardiomyocyte dysfunction in PPCM are not fully understood.
Purpose of the Study:
- To investigate the molecular pathways involved in PPCM using transcriptome-wide RNA sequencing.
- To identify key genes and signaling pathways contributing to PPCM pathogenesis.
Main Methods:
- RNA sequencing of left ventricles from PPCM patients and healthy controls.
- Differential gene expression analysis and Ingenuity Pathway Analysis (IPA).
- Upstream regulator and integrated network analyses.
Main Results:
- Identified 2891 differentially expressed genes in PPCM ventricles.
- Revealed activation of protein ubiquitination, EIF2 signaling, mitochondrial dysfunction, and apoptosis pathways.
- Highlighted suppression of CLPP and activation of COPS5 and TEAD1, indicating disrupted proteostasis and translational control.
Conclusions:
- PPCM is characterized by a collapse of proteostasis and impaired translational homeostasis.
- Findings suggest potential therapeutic targets in mitochondria, protein quality control, integrated stress response, and COP9 signaling pathways.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Regulation of the Unfolded Protein Response
Cardiomyopathy II: Dilated Cardiomyopathy

